Evidence map›Paper›PMID 36179013›Full record

ArticleCannabis and cannabinoid research2024

Δ

Catherine F Moore, Catherine M Davis, Cristina Sempio, Jost Klawitter, Uwe Christians, Elise M Weerts

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cannabis and cannabinoid research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.Current topics in behavioral neurosciences · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. ΔDrug and alcohol dependence reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Catherine F MooreDivision of Behavioral Biology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-0198-4788
Catherine M DavisDepartment of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Cristina SempioiC42 Clinical Research and Development, Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Jost KlawitteriC42 Clinical Research and Development, Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Uwe ChristiansiC42 Clinical Research and Development, Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Elise M WeertsDivision of Behavioral Biology, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
University of Colorado Anschutz Medical Campus · USJohns Hopkins University · USUniformed Services University of the Health Sciences · US

Funding

Development of a preclinical cannabinoid vaping modelR21DA046154 · NIDA · JOHNS HOPKINS UNIVERSITY · PI WEERTS, ELISE M · 2018 to 2019
$450k
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CannabisHallucinogensAnimalsCannabinoid Receptor AgonistsDronabinolFemaleMaleRatsRats, Sprague-DawleyRewardCannabinoid Receptor AgonistsDronabinolHallucinogenscannabisconditioned place preferencerewardTHCvapor exposure

Identifiers

PMID36179013
PMCPMC10874829
OpenAlexW4298126930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.